
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Post-streptococcal glomerulonephritis natural history, complications and prognosis
Introduction
Overview
Overview
The symptoms of post-streptococcal glomerulonephritis typically develop one to three weeks after exposure to group A streptococcal throat infection and 3 to 6 weeks after group A streptococcal skin infection. Common complications of post-streptococcal glomerulonephritis include severe nephritis, renal failure , atypical hemolytic uremic syndrome , refractory hypoxic respiratory failure, and seizures. Prognosis is generally excellent but depends upon age and co-morbidities.
Natural History, Complications, and Prognosis
Natural History, Complications, and Prognosis
Natural History
- The symptoms of post-streptococcal glomerulonephritis typically develop one to three weeks after exposure to group A streptococcal throat infection and 3 to 6 weeks after group A streptococcal skin infection.
- If left untreated, patients with post-streptococcal glomerulonephritis may progress to develop renal failure.[1]
Complications
Common complications of post-streptococcal glomerulonephritis include:[2][3][4]
- Severe nephritis
- Renal failure
- Atypical hemolytic uremic syndrome
- Refractory hypoxic respiratory failure
- Seizures
Prognosis
- Prognosis is generally excellent.[5][6]
- Some people develop recurrent proteinuria and renal dysfunction 10 to 40 years after the presentation.[7]
- Age and presence of comorbidities are the most important prognostic factors for PSGN.
- Children have an excellent prognosis with a <1% rate of azotemia, and a 3-10% rate of non-nephrotic range proteinuria, microhematuria, and hypertension.
- The prognosis of PSGN in children might vary depending on individual co-morbidities, such as diabetes, obesity, and low birth weight.[5]
- Elderly patients with PSGN who often have co-morbidities have a comparatively much poorer prognosis with a 60% rate of azotemia, 40% rate of congestive heart failure, and 20% rate of nephrotic syndrome.[8][9]
References
References
- ↑ Ayoob RM, Schwaderer AL (2016). “Acute Kidney Injury and Atypical Features during Pediatric Poststreptococcal Glomerulonephritis”. Int J Nephrol. 2016: 5163065. doi:10.1155/2016/5163065. PMC 5011525. PMID 27642522.
- ↑ Kakajiwala A, Bhatti T, Kaplan BS, Ruebner RL, Copelovitch L (February 2016). “Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab?”. Clin Kidney J. 9 (1): 90–6. doi:10.1093/ckj/sfv119. PMC 4720198. PMID 26798467.
- ↑ Mara-Koosham G, Stoltze K, Aday J, Rendon P (2016). “Pulmonary Renal Syndrome After Streptococcal Pharyngitis: A Case Report”. J Investig Med High Impact Case Rep. 4 (2): 2324709616646127. doi:10.1177/2324709616646127. PMC 4871206. PMID 27231692.
- ↑ Adikari M, Priyangika D, Marasingha I, Thamotheram S, Premawansa G (September 2014). “Post-streptococcal glomerulonephritis leading to posterior reversible encephalopathy syndrome: a case report”. BMC Res Notes. 7: 644. doi:10.1186/1756-0500-7-644. PMC 4175190. PMID 25218027.
- ↑ 5.0 5.1 Rodriguez-Iturbe B, Musser JM (October 2008). “The current state of poststreptococcal glomerulonephritis”. J. Am. Soc. Nephrol. 19 (10): 1855–64. doi:10.1681/ASN.2008010092. PMID 18667731.
- ↑ Tejani A, Ingulli E (1990). “Poststreptococcal glomerulonephritis. Current clinical and pathologic concepts”. Nephron. 55 (1): 1–5. doi:10.1159/000185909. PMID 2191230.
- ↑ Pinto SW, Sesso R, Vasconcelos E, Watanabe YJ, Pansute AM (August 2001). “Follow-up of patients with epidemic poststreptococcal glomerulonephritis”. Am. J. Kidney Dis. 38 (2): 249–55. doi:10.1053/ajkd.2001.26083. PMID 11479149.
- ↑ Melby PC, Musick WD, Luger AM, Khanna R (1987). “Poststreptococcal glomerulonephritis in the elderly. Report of a case and review of the literature”. Am J Nephrol. 7 (3): 235–40. PMID 3631152.
- ↑ Washio M, Oh Y, Okuda S, Yanase T, Miishima C, Fujimi S; et al. (1994). “Clinicopathological study of poststreptococcal glomerulonephritis in the elderly”. Clin Nephrol. 41 (5): 265–70. PMID 8050205.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
